Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Therapy Drugs
1.2.3 Gene Therapy Drugs
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Perspective (2020-2031)
2.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Growth Trends by Region
2.2.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell and Gene Therapy (CGT) Pharmaceuticals Historic Market Size by Region (2020-2025)
2.2.3 Cell and Gene Therapy (CGT) Pharmaceuticals Forecasted Market Size by Region (2026-2031)
2.3 Cell and Gene Therapy (CGT) Pharmaceuticals Market Dynamics
2.3.1 Cell and Gene Therapy (CGT) Pharmaceuticals Industry Trends
2.3.2 Cell and Gene Therapy (CGT) Pharmaceuticals Market Drivers
2.3.3 Cell and Gene Therapy (CGT) Pharmaceuticals Market Challenges
2.3.4 Cell and Gene Therapy (CGT) Pharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy (CGT) Pharmaceuticals Players by Revenue
3.1.1 Global Top Cell and Gene Therapy (CGT) Pharmaceuticals Players by Revenue (2020-2025)
3.1.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Players (2020-2025)
3.2 Global Top Cell and Gene Therapy (CGT) Pharmaceuticals Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy (CGT) Pharmaceuticals Revenue
3.4 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy (CGT) Pharmaceuticals Revenue in 2024
3.5 Global Key Players of Cell and Gene Therapy (CGT) Pharmaceuticals Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy (CGT) Pharmaceuticals, Product and Application
3.7 Global Key Players of Cell and Gene Therapy (CGT) Pharmaceuticals, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy (CGT) Pharmaceuticals Breakdown Data by Type
4.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Historic Market Size by Type (2020-2025)
4.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Forecasted Market Size by Type (2026-2031)
5 Cell and Gene Therapy (CGT) Pharmaceuticals Breakdown Data by Application
5.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Historic Market Size by Application (2020-2025)
5.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (2020-2031)
6.2 North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2020-2025)
6.4 North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (2020-2031)
7.2 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2020-2025)
7.4 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (2020-2031)
8.2 Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (2020-2031)
9.2 Latin America Cell and Gene Therapy (CGT) Pharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2020-2025)
9.4 Latin America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (2020-2031)
10.2 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vericel
11.1.1 Vericel Company Details
11.1.2 Vericel Business Overview
11.1.3 Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.1.4 Vericel Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.1.5 Vericel Recent Development
11.2 Castle Creek
11.2.1 Castle Creek Company Details
11.2.2 Castle Creek Business Overview
11.2.3 Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.2.4 Castle Creek Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.2.5 Castle Creek Recent Development
11.3 Terumo
11.3.1 Terumo Company Details
11.3.2 Terumo Business Overview
11.3.3 Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.3.4 Terumo Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.3.5 Terumo Recent Development
11.4 Nipro
11.4.1 Nipro Company Details
11.4.2 Nipro Business Overview
11.4.3 Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.4.4 Nipro Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.4.5 Nipro Recent Development
11.5 BioCardia
11.5.1 BioCardia Company Details
11.5.2 BioCardia Business Overview
11.5.3 BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.5.4 BioCardia Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.5.5 BioCardia Recent Development
11.6 Sanpower Group
11.6.1 Sanpower Group Company Details
11.6.2 Sanpower Group Business Overview
11.6.3 Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.6.4 Sanpower Group Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.6.5 Sanpower Group Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.7.4 Novartis Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.7.5 Novartis Recent Development
11.8 Gilead Sciences, Inc./Fosun Kite
11.8.1 Gilead Sciences, Inc./Fosun Kite Company Details
11.8.2 Gilead Sciences, Inc./Fosun Kite Business Overview
11.8.3 Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.8.4 Gilead Sciences, Inc./Fosun Kite Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.8.5 Gilead Sciences, Inc./Fosun Kite Recent Development
11.9 BMS
11.9.1 BMS Company Details
11.9.2 BMS Business Overview
11.9.3 BMS Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.9.4 BMS Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.9.5 BMS Recent Development
11.10 JW (Cayman) Therapeutics
11.10.1 JW (Cayman) Therapeutics Company Details
11.10.2 JW (Cayman) Therapeutics Business Overview
11.10.3 JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.10.4 JW (Cayman) Therapeutics Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.10.5 JW (Cayman) Therapeutics Recent Development
11.11 Legend Biotech Corp./Johnson & Johnson
11.11.1 Legend Biotech Corp./Johnson & Johnson Company Details
11.11.2 Legend Biotech Corp./Johnson & Johnson Business Overview
11.11.3 Legend Biotech Corp./Johnson & Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.11.4 Legend Biotech Corp./Johnson & Johnson Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.11.5 Legend Biotech Corp./Johnson & Johnson Recent Development
11.12 Innovent Biologics, Inc./IASO Biotherapeutics
11.12.1 Innovent Biologics, Inc./IASO Biotherapeutics Company Details
11.12.2 Innovent Biologics, Inc./IASO Biotherapeutics Business Overview
11.12.3 Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.12.4 Innovent Biologics, Inc./IASO Biotherapeutics Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.12.5 Innovent Biologics, Inc./IASO Biotherapeutics Recent Development
11.13 Juventas/CASI
11.13.1 Juventas/CASI Company Details
11.13.2 Juventas/CASI Business Overview
11.13.3 Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.13.4 Juventas/CASI Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.13.5 Juventas/CASI Recent Development
11.14 CARsgen Therapeutics Holdings
11.14.1 CARsgen Therapeutics Holdings Company Details
11.14.2 CARsgen Therapeutics Holdings Business Overview
11.14.3 CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.14.4 CARsgen Therapeutics Holdings Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.14.5 CARsgen Therapeutics Holdings Recent Development
11.15 Huadong Medicine
11.15.1 Huadong Medicine Company Details
11.15.2 Huadong Medicine Business Overview
11.15.3 Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.15.4 Huadong Medicine Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.15.5 Huadong Medicine Recent Development
11.16 inno.N
11.16.1 inno.N Company Details
11.16.2 inno.N Business Overview
11.16.3 inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.16.4 inno.N Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.16.5 inno.N Recent Development
11.17 lovance
11.17.1 lovance Company Details
11.17.2 lovance Business Overview
11.17.3 lovance Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.17.4 lovance Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.17.5 lovance Recent Development
11.18 Mesoblast
11.18.1 Mesoblast Company Details
11.18.2 Mesoblast Business Overview
11.18.3 Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.18.4 Mesoblast Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.18.5 Mesoblast Recent Development
11.19 Takeda
11.19.1 Takeda Company Details
11.19.2 Takeda Business Overview
11.19.3 Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.19.4 Takeda Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.19.5 Takeda Recent Development
11.20 Pierre fabre
11.20.1 Pierre fabre Company Details
11.20.2 Pierre fabre Business Overview
11.20.3 Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.20.4 Pierre fabre Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.20.5 Pierre fabre Recent Development
11.21 Aurion Biotech
11.21.1 Aurion Biotech Company Details
11.21.2 Aurion Biotech Business Overview
11.21.3 Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.21.4 Aurion Biotech Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.21.5 Aurion Biotech Recent Development
11.22 Gamida Cell
11.22.1 Gamida Cell Company Details
11.22.2 Gamida Cell Business Overview
11.22.3 Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.22.4 Gamida Cell Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.22.5 Gamida Cell Recent Development
11.23 CellTrans
11.23.1 CellTrans Company Details
11.23.2 CellTrans Business Overview
11.23.3 CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.23.4 CellTrans Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.23.5 CellTrans Recent Development
11.24 SiBiono Gene Technology
11.24.1 SiBiono Gene Technology Company Details
11.24.2 SiBiono Gene Technology Business Overview
11.24.3 SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.24.4 SiBiono Gene Technology Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.24.5 SiBiono Gene Technology Recent Development
11.25 Ferring
11.25.1 Ferring Company Details
11.25.2 Ferring Business Overview
11.25.3 Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.25.4 Ferring Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.25.5 Ferring Recent Development
11.26 Kyowa Kirin
11.26.1 Kyowa Kirin Company Details
11.26.2 Kyowa Kirin Business Overview
11.26.3 Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.26.4 Kyowa Kirin Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.26.5 Kyowa Kirin Recent Development
11.27 uniQure
11.27.1 uniQure Company Details
11.27.2 uniQure Business Overview
11.27.3 uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.27.4 uniQure Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.27.5 uniQure Recent Development
11.28 Roche
11.28.1 Roche Company Details
11.28.2 Roche Business Overview
11.28.3 Roche Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.28.4 Roche Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.28.5 Roche Recent Development
11.29 PTC Therapeutics
11.29.1 PTC Therapeutics Company Details
11.29.2 PTC Therapeutics Business Overview
11.29.3 PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.29.4 PTC Therapeutics Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.29.5 PTC Therapeutics Recent Development
11.30 BioMarin
11.30.1 BioMarin Company Details
11.30.2 BioMarin Business Overview
11.30.3 BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.30.4 BioMarin Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.30.5 BioMarin Recent Development
11.31 CSL
11.31.1 CSL Company Details
11.31.2 CSL Business Overview
11.31.3 CSL Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.31.4 CSL Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.31.5 CSL Recent Development
11.32 Sarepta
11.32.1 Sarepta Company Details
11.32.2 Sarepta Business Overview
11.32.3 Sarepta Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.32.4 Sarepta Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.32.5 Sarepta Recent Development
11.33 AnGes
11.33.1 AnGes Company Details
11.33.2 AnGes Business Overview
11.33.3 AnGes Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.33.4 AnGes Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.33.5 AnGes Recent Development
11.34 bluebird bio
11.34.1 bluebird bio Company Details
11.34.2 bluebird bio Business Overview
11.34.3 bluebird bio Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.34.4 bluebird bio Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.34.5 bluebird bio Recent Development
11.35 Krystal Biotech
11.35.1 Krystal Biotech Company Details
11.35.2 Krystal Biotech Business Overview
11.35.3 Krystal Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Introduction
11.35.4 Krystal Biotech Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
11.35.5 Krystal Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell Therapy Drugs
Table 3. Key Players of Gene Therapy Drugs
Table 4. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Region (2020-2025)
Table 8. Global Cell and Gene Therapy (CGT) Pharmaceuticals Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Region (2026-2031)
Table 10. Cell and Gene Therapy (CGT) Pharmaceuticals Market Trends
Table 11. Cell and Gene Therapy (CGT) Pharmaceuticals Market Drivers
Table 12. Cell and Gene Therapy (CGT) Pharmaceuticals Market Challenges
Table 13. Cell and Gene Therapy (CGT) Pharmaceuticals Market Restraints
Table 14. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Players (2020-2025)
Table 16. Global Top Cell and Gene Therapy (CGT) Pharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals as of 2024)
Table 17. Ranking of Global Top Cell and Gene Therapy (CGT) Pharmaceuticals Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cell and Gene Therapy (CGT) Pharmaceuticals, Headquarters and Area Served
Table 20. Global Key Players of Cell and Gene Therapy (CGT) Pharmaceuticals, Product and Application
Table 21. Global Key Players of Cell and Gene Therapy (CGT) Pharmaceuticals, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Type (2020-2025)
Table 25. Global Cell and Gene Therapy (CGT) Pharmaceuticals Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Type (2026-2031)
Table 27. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Application (2020-2025)
Table 29. Global Cell and Gene Therapy (CGT) Pharmaceuticals Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Market Share by Application (2026-2031)
Table 31. North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country (2026-2031) & (US$ Million)
Table 46. Vericel Company Details
Table 47. Vericel Business Overview
Table 48. Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 49. Vericel Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 50. Vericel Recent Development
Table 51. Castle Creek Company Details
Table 52. Castle Creek Business Overview
Table 53. Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 54. Castle Creek Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 55. Castle Creek Recent Development
Table 56. Terumo Company Details
Table 57. Terumo Business Overview
Table 58. Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 59. Terumo Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 60. Terumo Recent Development
Table 61. Nipro Company Details
Table 62. Nipro Business Overview
Table 63. Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 64. Nipro Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 65. Nipro Recent Development
Table 66. BioCardia Company Details
Table 67. BioCardia Business Overview
Table 68. BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 69. BioCardia Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 70. BioCardia Recent Development
Table 71. Sanpower Group Company Details
Table 72. Sanpower Group Business Overview
Table 73. Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 74. Sanpower Group Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 75. Sanpower Group Recent Development
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 79. Novartis Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Gilead Sciences, Inc./Fosun Kite Company Details
Table 82. Gilead Sciences, Inc./Fosun Kite Business Overview
Table 83. Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 84. Gilead Sciences, Inc./Fosun Kite Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 85. Gilead Sciences, Inc./Fosun Kite Recent Development
Table 86. BMS Company Details
Table 87. BMS Business Overview
Table 88. BMS Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 89. BMS Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 90. BMS Recent Development
Table 91. JW (Cayman) Therapeutics Company Details
Table 92. JW (Cayman) Therapeutics Business Overview
Table 93. JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 94. JW (Cayman) Therapeutics Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 95. JW (Cayman) Therapeutics Recent Development
Table 96. Legend Biotech Corp./Johnson & Johnson Company Details
Table 97. Legend Biotech Corp./Johnson & Johnson Business Overview
Table 98. Legend Biotech Corp./Johnson & Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 99. Legend Biotech Corp./Johnson & Johnson Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 100. Legend Biotech Corp./Johnson & Johnson Recent Development
Table 101. Innovent Biologics, Inc./IASO Biotherapeutics Company Details
Table 102. Innovent Biologics, Inc./IASO Biotherapeutics Business Overview
Table 103. Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 104. Innovent Biologics, Inc./IASO Biotherapeutics Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 105. Innovent Biologics, Inc./IASO Biotherapeutics Recent Development
Table 106. Juventas/CASI Company Details
Table 107. Juventas/CASI Business Overview
Table 108. Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 109. Juventas/CASI Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 110. Juventas/CASI Recent Development
Table 111. CARsgen Therapeutics Holdings Company Details
Table 112. CARsgen Therapeutics Holdings Business Overview
Table 113. CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 114. CARsgen Therapeutics Holdings Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 115. CARsgen Therapeutics Holdings Recent Development
Table 116. Huadong Medicine Company Details
Table 117. Huadong Medicine Business Overview
Table 118. Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 119. Huadong Medicine Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 120. Huadong Medicine Recent Development
Table 121. inno.N Company Details
Table 122. inno.N Business Overview
Table 123. inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 124. inno.N Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 125. inno.N Recent Development
Table 126. lovance Company Details
Table 127. lovance Business Overview
Table 128. lovance Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 129. lovance Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 130. lovance Recent Development
Table 131. Mesoblast Company Details
Table 132. Mesoblast Business Overview
Table 133. Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 134. Mesoblast Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 135. Mesoblast Recent Development
Table 136. Takeda Company Details
Table 137. Takeda Business Overview
Table 138. Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 139. Takeda Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 140. Takeda Recent Development
Table 141. Pierre fabre Company Details
Table 142. Pierre fabre Business Overview
Table 143. Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 144. Pierre fabre Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 145. Pierre fabre Recent Development
Table 146. Aurion Biotech Company Details
Table 147. Aurion Biotech Business Overview
Table 148. Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 149. Aurion Biotech Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 150. Aurion Biotech Recent Development
Table 151. Gamida Cell Company Details
Table 152. Gamida Cell Business Overview
Table 153. Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 154. Gamida Cell Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 155. Gamida Cell Recent Development
Table 156. CellTrans Company Details
Table 157. CellTrans Business Overview
Table 158. CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 159. CellTrans Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 160. CellTrans Recent Development
Table 161. SiBiono Gene Technology Company Details
Table 162. SiBiono Gene Technology Business Overview
Table 163. SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 164. SiBiono Gene Technology Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 165. SiBiono Gene Technology Recent Development
Table 166. Ferring Company Details
Table 167. Ferring Business Overview
Table 168. Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 169. Ferring Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 170. Ferring Recent Development
Table 171. Kyowa Kirin Company Details
Table 172. Kyowa Kirin Business Overview
Table 173. Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 174. Kyowa Kirin Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 175. Kyowa Kirin Recent Development
Table 176. uniQure Company Details
Table 177. uniQure Business Overview
Table 178. uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 179. uniQure Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 180. uniQure Recent Development
Table 181. Roche Company Details
Table 182. Roche Business Overview
Table 183. Roche Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 184. Roche Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 185. Roche Recent Development
Table 186. PTC Therapeutics Company Details
Table 187. PTC Therapeutics Business Overview
Table 188. PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 189. PTC Therapeutics Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 190. PTC Therapeutics Recent Development
Table 191. BioMarin Company Details
Table 192. BioMarin Business Overview
Table 193. BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 194. BioMarin Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 195. BioMarin Recent Development
Table 196. CSL Company Details
Table 197. CSL Business Overview
Table 198. CSL Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 199. CSL Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 200. CSL Recent Development
Table 201. Sarepta Company Details
Table 202. Sarepta Business Overview
Table 203. Sarepta Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 204. Sarepta Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 205. Sarepta Recent Development
Table 206. AnGes Company Details
Table 207. AnGes Business Overview
Table 208. AnGes Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 209. AnGes Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 210. AnGes Recent Development
Table 211. bluebird bio Company Details
Table 212. bluebird bio Business Overview
Table 213. bluebird bio Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 214. bluebird bio Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 215. bluebird bio Recent Development
Table 216. Krystal Biotech Company Details
Table 217. Krystal Biotech Business Overview
Table 218. Krystal Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product
Table 219. Krystal Biotech Revenue in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025) & (US$ Million)
Table 220. Krystal Biotech Recent Development
Table 221. Research Programs/Design for This Report
Table 222. Key Data Information from Secondary Sources
Table 223. Key Data Information from Primary Sources
Table 224. Authors List of This Report


List of Figures
Figure 1. Cell and Gene Therapy (CGT) Pharmaceuticals Picture
Figure 2. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Type: 2024 VS 2031
Figure 4. Cell Therapy Drugs Features
Figure 5. Gene Therapy Drugs Features
Figure 6. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Cell and Gene Therapy (CGT) Pharmaceuticals Report Years Considered
Figure 12. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Region: 2024 VS 2031
Figure 15. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Players in 2024
Figure 16. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Cell and Gene Therapy (CGT) Pharmaceuticals Revenue in 2024
Figure 18. North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Country (2020-2031)
Figure 20. United States Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Country (2020-2031)
Figure 24. Germany Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Region (2020-2031)
Figure 32. China Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Country (2020-2031)
Figure 40. Mexico Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Country (2020-2031)
Figure 44. Turkey Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Cell and Gene Therapy (CGT) Pharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Vericel Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 48. Castle Creek Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 49. Terumo Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 50. Nipro Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 51. BioCardia Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 52. Sanpower Group Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 53. Novartis Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 54. Gilead Sciences, Inc./Fosun Kite Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 55. BMS Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 56. JW (Cayman) Therapeutics Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 57. Legend Biotech Corp./Johnson & Johnson Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 58. Innovent Biologics, Inc./IASO Biotherapeutics Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 59. Juventas/CASI Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 60. CARsgen Therapeutics Holdings Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 61. Huadong Medicine Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 62. inno.N Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 63. lovance Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 64. Mesoblast Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 65. Takeda Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 66. Pierre fabre Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 67. Aurion Biotech Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 68. Gamida Cell Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 69. CellTrans Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 70. SiBiono Gene Technology Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 71. Ferring Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 72. Kyowa Kirin Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 73. uniQure Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 74. Roche Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 75. PTC Therapeutics Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 76. BioMarin Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 77. CSL Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 78. Sarepta Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 79. AnGes Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 80. bluebird bio Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 81. Krystal Biotech Revenue Growth Rate in Cell and Gene Therapy (CGT) Pharmaceuticals Business (2020-2025)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit